Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;39(9):1155-1165.
doi: 10.1002/stem.3391. Epub 2021 May 18.

Radiotherapy and the immune system: More than just immune suppression

Michael Rückert  1   2   3 , Ann-Sophie Flohr  1   2   3 , Markus Hecht  2   3   4 , Udo S Gaipl  1   2   3   4
Affiliations
Review

Radiotherapy and the immune system: More than just immune suppression

Michael Rückert et al. Stem Cells. 2021 Sep.

Abstract

Radiotherapy (RT) is still one of the standard cancer therapies, with up to two third of all cancer patients with solid tumors being irradiated in the course of their disease. The aim of using ionizing radiation in fractionated treatment schedules was always to achieve local tumor control by inducing DNA damage which can be repaired by surrounding normal tissue but leads to cell death in tumor cells. Meanwhile, it is known that RT also has immunological effects reshaping the tumor microenvironment. Nevertheless, RT alone often fails to elicit potent antitumor immune responses as these effects can be immunostimulatory as well as immunosuppressive. Here, we discuss how immunotherapies can be exploited in combined therapies to boost RT-induced antitumor immune responses or to counteract preexisting and RT-mediated immunosuppression to improve local and systemic tumor control. Furthermore, we highlight some parameters of radioimmunotherapies (RITs) which are under investigation for potential optimizations and how RIT approaches are tested in first phases II and III trials. Finally, we discuss how RT might affect normal and cancer stem cells.

Keywords: cancer; cancer stem cells; clinical translation; immune checkpoints; immunogenicity; immunotherapy; radiotherapy.

PubMed Disclaimer

References

REFERENCES

    1. Prasanna A, Ahmed MM, Mohiuddin M, Coleman CN. Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy. J Thorac Dis. 2014;6(4):287-302. https://doi.org/10.3978/j.issn.2072-1439.2014.01.14.
    1. Frey B, Rückert M, Deloch L, et al. Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases. Immunol Rev. 2017a;280(1):231-248. https://doi.org/10.1111/imr.12572.
    1. Frey B, Rückert M, Weber J, et al. Hypofractionated irradiation has immune stimulatory potential and induces a timely restricted infiltration of immune cells in colon cancer tumors. Front Immunol. 2017;8:231. https://doi.org/10.3389/fimmu.2017.00231.
    1. Asur R, Butterworth KT, Penagaricano JA, Prise KM, Griffin RJ. High dose bystander effects in spatially fractionated radiation therapy. Cancer Lett. 2015;356(1):52-57. https://doi.org/10.1016/j.canlet.2013.10.032.
    1. Deloch L, Derer A, Hartmann J, Frey B, Fietkau R, Gaipl US. Modern radiotherapy concepts and the impact of radiation on immune activation. Front Oncol. 2016;6:141. https://doi.org/10.3389/fonc.2016.00141.

Publication types